Skip to main content

The timing of development and subsequent clinical course of heart failure after a myocardial infarction

Torabi, Azam; Cleland, John G.F.; Khan, Nasrin K.; Loh, Puan H.; Clark, Andrew L.; Alamgir, Farqad; Caplin, John L.; Rigby, Alan S.; Goode, Kevin

Authors

Azam Torabi

John G.F. Cleland

Nasrin K. Khan

Puan H. Loh

Andrew L. Clark A.L.Clark@hull.ac.uk

Farqad Alamgir

John L. Caplin

Alan S. Rigby A.Rigby@hull.ac.uk

Profile Image

Dr Kevin Goode K.M.Goode@hull.ac.uk
Research Systems Project Manager / Business Analyst



Abstract

Aims: Myocardial infarction (MI) is a common cause of heart failure (HF), which may develop early and persist or resolve, or develop late. The cumulative incidence, persistence, and resolution of HF after MI are poorly described. The aim of this study is to describe the natural history and prognosis of HF after an MI. Methods and results: Patients with a death or discharge diagnosis of MI in 1998 were identified from records of hospitals providing services to a local community of 600 000 people. Records were scrutinized to identify the development of HF, defined as signs and symptoms consistent with that diagnosis and treated with loop diuretics. HF was considered to have resolved if diuretics could be stopped without recurrent symptoms. Totally, 896 patients were identified of whom 54% had died by December 2005. During the index admission, 199 (22.2%) patients died, many with HF, and a further 182 (20.3%) patients developed HF that persisted until discharge, of whom 121 died subsequent to discharge. Of 74 patients with transient HF t hat resolved before discharge, 41 had recurrent HF and 38 died during follow-up. After discharge, 145 (33%) patients developed HF for the first time, of whom 76 died during follow-up. Overall, of 281 deaths occurring after discharge, 235 (83.6%) were amongst inpatients who first developed HF. Conclusion: The development of HF precedes death in most patients who die in the short- or long-term following an MI. Prevention of HF, predominantly by reducing the extent of myocardial damage and recurrent MI, and subsequent management could have a substantial impact on prognosis. © The Author 2008.

Journal Article Type Article
Publication Date Apr 1, 2008
Journal EUROPEAN HEART JOURNAL
Print ISSN 0195-668X
Electronic ISSN 1522-9645
Publisher Oxford University Press (OUP)
Peer Reviewed Peer Reviewed
Volume 29
Issue 7
Pages 859-870
APA6 Citation Torabi, A., Cleland, J. G., Khan, N. K., Loh, P. H., Clark, A. L., Alamgir, F., …Goode, K. (2008). The timing of development and subsequent clinical course of heart failure after a myocardial infarction. European Heart Journal, 29(7), 859-870. https://doi.org/10.1093/eurheartj/ehn096
DOI https://doi.org/10.1093/eurheartj/ehn096
Keywords Cardiology and Cardiovascular Medicine
;